Those Medicare beneficiaries and their physicians managing conditions related to chronic atrial fibrillation or venous thromboembolism will benefit greatly through the use of the home test, CMS Acting Administrator Kerry Weems said. Medicares prior policy only provided home test coverage for Medicare patients with mechanical heart valves who are on warfarin. The Centers for Medicare & Medicaid Services today expanded Medicare coverage for home blood testing of prothrombin time International Normalized Ratio to include beneficiaries who are using the drug warfarin, an anticoagulant medication, for chronic atrial fibrillation or venous thromboembolism. MEDICARE EXPANDS COVERAGE FOR HOME BLOOD TESTING OF PROTHROMBIN TIME INTERNATIONAL NORMALIZED RATIO The patient must undergo a face-to-face educational program on anticoagulation management and must have demonstrated the correct use of the device prior to its use in the home Medicare Expands Coverage For Home Blood Testing Of Prothrombin Time International Normalized Ratio.The patient must have been anticoagulated for at least 3 months prior to use of the home INR device.Which Patients Qualify for INR Home Testing Home PT/INR Monitoring for Anticoagulation Management – Coverage and Claim Review
0 kommentar(er)
